CodeMap® 

11/18/2021 2020 Part B Utilization Data Loaded
150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2022
2021

Physician Fee Schedule

2022
2021

OPPS Fee Schedule

2022-January
2021-October

ASC Fee Schedule

2022-January
2021-October

APC Codes

2022-January
2021-October

DRG Codes

2022
2021

ASP Drug Pricing Files

January 2022
October 2021


CMS Transmittals



Shipping update: 2022 CodeMap Manuals beginning shipping 1/19. All orders will be shipped by January 31.


CodeMap® Compliance Briefing: July 17, 2014


Editor's Welcome: As we discussed last week, the Protecting Access to Medicare Act of 2014 (PAMA) adds a new section to the Social Security Act, which will radically change how CMS sets reimbursement rates for clinical laboratory tests. This newly created legislation sets forth a new market-based payment system for all laboratory tests presently paid from either the Medicare Clinical Laboratory Fee Schedule or the Medicare Physician Fee Schedule. While PAMA is quite specific concerning many aspects of the market-based system, many other aspects will need to be more specifically defined in upcoming regulations. Today, we will explore how PAMA will create and implement a market-based payment system for Medicare. As always, please forward any comments, questions, or suggestions via email.

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap┬« is a Registered Trademark of Wheaton Partners, LLC.